Trial intelligence / Profile preview

Nicotine Lozenge for Smokeless Tobacco Users

NCT00888459Phase 2Completed

Sponsor
Mayo Clinic
Start
Apr 2008
Primary completion
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by Mayo Clinic. Started Apr 2008; status: completed.

02

Drugs

nicotine
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00888459.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00888459.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call